AzTrials
AzTrials

Rotator Cuff TearsNCT05214651

A Clinical Research on Repair of Massive-large Rotator Cuff Tears

A study testing novel double row and suture bridge double row in people with Rotator Cuff Tears, run by Peking University Third Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study is designed as a randomized controlled trial, a total of 52 participants with large - massive rotator cuff tears will be prospectively enrolled and randomly divided into 2 groups according to the applied repairing technique: novel double row technique group and suture bridge double row technique group. Read more about this study

Who is it for?
Ages 17 to 75 years
Conditions the study is for
Rotator Cuff Tears
What is being tested?
novel double row and suture bridge double row
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteChina
Study dates
8 Jun 2022to May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 75 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • preoperative magnetic resonance imaging (MRI) diagnosis of a large - massive sized rotator cuff tear (>3cm), which was confirmed during operation
  • chronic tear
  • older than 17 years and younger than 75 years
  • without surgical contraindications and willing to participate

Who cannot join

  • poor quality rotator cuff and irreparable tear
  • severe glenohumeral arthritis
  • previous shoulder surgery
  • accompanied by dislocation or fracture of shoulder
  • refusal to participate

Trial locations and contacts

1 site in 1 country.

Ping Liu, M.D. contact

01082267020

bjusmlp@126.com

China1 site, 1 recruiting
  • Institute of Sports Medicine, Peking University Third Hospital

    Beijing, Beijing Municipality, 100191

    Ping Liu, M.D., 01082267020, bjusmlp@126.com

    Recruiting

Other trials in China

About this study

Official title: A Clinical Research on Arthroscopic Repair of Massive-large Rotator Cuff Tears With a Novel Inner Fixation Technique

The study is designed as a randomized controlled trial, a total of 52 participants with large - massive rotator cuff tears will be prospectively enrolled and randomly divided into 2 groups according to the applied repairing technique: novel double row technique group and suture bridge double row technique group. The functional outcome was measured at the preoperatively, 3, 6, 12 and 24 months postoperatively, using the visual analog scale (VAS) for pain, active and passive ROM, Constant score, American Shoulder and Elbow Surgeons (ASES) score, and University of California Los Angeles shoulder score (UCLA). The anatomic outcome was evaluated using magnetic resonance imaging at 3, 6, 12 and 24 months postoperatively. The clinical results were compared between the novel double row technique group and suture bridge double row technique group.

Read the detailed description

The purpose of this study is to compare a novel double row technique with suture bridge double row technique in the arthroscopic repair of massive-large rotator cuff tears clinically. The study is designed as a randomized controlled trial. A total of 52 participants with large - massive rotator cuff tears will be prospectively enrolled and randomly divided into 2 groups according to the applied repairing technique: novel double row technique group and suture bridge double row technique group.

The investigators prospectively enrolled participants who met the following inclusion criteria: preoperative magnetic resonance imaging (MRI) diagnosis of a large - massive sized rotator cuff tear (>3cm), which was confirmed during operation; chronic tear; older than 17 years and younger than 75 years; without surgical contraindications and willing to participate. The investigators excluded patients with poor quality rotator cuff and irreparable tear; severe glenohumeral arthritis; previous shoulder surgery; accompanied by dislocation or fracture of shoulder; refusal to participate.

Each participant, assigned using a randomization table, was assessed by a clinical researcher, who was blinded to the grouping, at the following time points: preoperatively; 3, 6, 12 and 24 months postoperatively. The visual analog scale (VAS) for pain, active and passive ROM, and functional scores were assessed at each time point. The functional scores including the Constant score, American Shoulder and Elbow Surgeons (ASES) score, and University of California Los Angeles shoulder score (UCLA). Anatomic healing was evaluated using MRI at 3, 6, 12 and 24 months postoperatively. An experienced musculoskeletal radiologist interpreted the MRI and determined the healing failure rate. On the basis of the MRI findings, type IV or V of the Sugaya classification was regarded as healing failure.

Based on the previous study, the retear rate of large to massive rotator cuff tears treated with suture bridge double row technique was assumed to be 28.3%. Based on the investigators' previous clinical data on large to massive rotator cuff tears, it is assumed that the retear rate of large to massive rotator cuff tears treated with novel double row technique is 1.0%.

Differences in primary end points between the two groups were analyzed using chi-square tests. Set α=0.05, power is 0.80, the sample ratio of the two groups was 1:1. The sample size was estimated with PASS 15.0. A total of 46 patients, with 23 in each group, had sufficient power to detect statistical differences between groups. In consideration of the uncertainty of the effect and the possible loss of follow-up, the design effect was assumed to 10%. Therefore, the total sample size of this study should be more than 46÷90%≈51. To facilitate randomization, the sample size was determined to be 52 patients, with 26 patients in each group.

Variables such as age, sex, tear size, and functional scores were analyzed, and their mean values were obtained. Continuous data were presented as the mean ± SD, and were analyzed using the independent t test. The retear rates between the two groups were analyzed using chi-square tests. Differences in values between the 2 groups were set at P < .05 to be statistically significant. All statistical analyses were performed using SPSS version 15.0

Being tested
novel double row, suture bridge double row
Keywords
novel double row technique, suture bridge double row technique, massive-large rotator cuff tears, retear rate
Medical subject headings
Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • novel double rowProcedure or surgery

    The large - massive rotator cuff tears in in this group will be treated using a novel double row repairing techniques.

  • suture bridge double rowProcedure or surgery

    The large - massive rotator cuff tears in in this group will be treated using a suture bridge double row repairing techniques.

Study groups in NCT05214651
Study groupRoleWhat they receive
novel double row groupExperimentalThis is the experimental group, and 26 participants will be enrolled, a novel double row technique will be using to repair the large - massive rotator cuff tears in in this group.
Receives: Procedure: novel double row
suture bridge double row groupActive comparatorThis is the control group, and 26 participants will be enrolled, a suture bridge double row technique will be using to repair the large - massive rotator cuff tears in in this group in routine.
Receives: Procedure: suture bridge double row

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The retear rate of large to massive rotator cuff tears

    This study statistically compared the retear rate of large to massive rotator cuff tears treated with suture bridge double row technique with that treated with novel double row technique.

    Measured: The incidence of retear during 24 months postoperatively

Secondary outcomes (1)
  1. functional scores of the shoulder

    This study statistically compared the functional scores of the shoulder of large to massive rotator cuff tears treated with suture bridge double row technique with that treated with novel double row technique. The functional scores including the Constant score (0-100), American Shoulder and Elbow Surgeons score (0-100), and University of California Los Angeles shoulder score (2-35). Higher scores mean a better outcome.

    Measured: functional scores of the shoulder were assessed at following time points: preoperatively; 3, 6, 12 and 24 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2022
  2. Study start8 Jun 2022
  3. Primary completionMay 2026 (estimated)
  4. Study completionMay 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05214651
Sponsor's protocol ID
M2021389
Status last verified
Jan 2024
First submitted
29 Dec 2021
Last updated
17 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing novel double row and suture bridge double row in people with Rotator Cuff Tears, run by Peking University Third Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ping Liu, M.D. (01082267020, bjusmlp@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The retear rate of large to massive rotator cuff tears (time frame: The incidence of retear during 24 months postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in